Nektar Therapeutics Reports Financial Results for the Second Quarter of 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. SPY
3. VRTX
4. LGND
5. ONON
6. PSKY
7. META
8. ARAI
9. MA
10. ACN

Go back to Nektar Therapeutics Reports Financial Results for the Second Quarter of 2018
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 66.30 -0.54 (0.81%)
Previous Close $66.84    52 Week High $19.98 
Open $67.08    52 Week Low $10.52 
Day High $68.00    P/E N/A 
Day Low $66.23    EPS $-1.45 
Volume 81,133